Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?

C Russell, S Lange, F Kouyoumdjian, A Butler… - Harm Reduction …, 2022 - Springer
Opioid agonist treatment (OAT) is the primary intervention for opioid use disorder (OUD) in
Canada and the USA. Yet, a number of barriers contribute to sub-optimal treatment uptake …

Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives

SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

[HTML][HTML] Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in …

D Aldabergenov, L Reynolds, J Scott… - International Journal of …, 2022 - Elsevier
Background The coronavirus pandemic resulted in many changes which had the potential to
impact mortality related to opioid agonist therapy (OAT; methadone, buprenorphine) …

Assessment of community-level vulnerability and access to medications for opioid use disorder

PJ Joudrey, M Kolak, Q Lin, S Paykin… - JAMA Network …, 2022 - jamanetwork.com
Importance Given that COVID-19 and recent natural disasters exacerbated the shortage of
medication for opioid use disorder (MOUD) services and were associated with increased …

Treatment of hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: the potential role of telehealth, medications …

A Sivakumar, L Madden, E DiDomizio, A Eller… - International Journal of …, 2022 - Elsevier
Background Healthcare delivery was disrupted during the COVID-19 pandemic, requiring
minimized in-person contact between patients and clinicians. During the pandemic, people …

Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior

P Mitchell, S Samsel, KM Curtin, A Price… - Social Science & …, 2022 - Elsevier
Drug overdose is the leading cause of accidental death in the US with deaths from opioid
overdose occurring at a higher rate in rural areas. The gaps in the provision of healthcare …

[HTML][HTML] Trends in engagement with opioid use disorder treatment among Medicaid beneficiaries during the COVID-19 pandemic

AS Tilhou, L Dague, B Saloner, D Beemon… - JAMA Health …, 2022 - jamanetwork.com
Importance Disruptions in care during the COVID-19 pandemic may have decreased access
to care for patients with opioid use disorder. Objective To examine trends in opioid use …

The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months

AS Bennett, T Townsend, L Elliott - International Journal of Drug Policy, 2022 - Elsevier
Background Concurrent opioid-related overdose and COVID-19 crises in the US have
imposed unprecedented challenges on people who use illicit opioids. Methods Using the …

Article Commentary: Research Priorities for Expanding access to Methadone Treatment for Opioid use Disorder in the United States: A National Institute on Drug …

PJ Joudrey, G Bart, RK Brooner, L Brown… - Substance …, 2021 - journals.sagepub.com
In the US, methadone treatment can only be provided to patients with opioid use disorder
(OUD) through federal and state-regulated opioid treatment programs (OTPs). There is a …

Ingestion of illicit substances by young children before and during the COVID-19 pandemic

BJ Raffa, S Schilling, MK Henry, V Ritter… - JAMA Network …, 2023 - jamanetwork.com
Importance Information about the trend in illicit substance ingestions among young children
during the pandemic is limited. Objectives To assess immediate and sustained changes in …